Evaluate HACOR socre utility and efficacy in predicting NIV and/or CPAP failure inpatients with COVID-19 associated respiratory failure.Propose adaptations to HACOR score based on the "state of art" of COVID-19
Evaluate HACOR socre utility and efficacy in predicting NIV and/or CPAP failure in
patients with COVID-19 associated respiratory failure.
Propose adaptations to HACOR score based on the "state of art" of COVID-19
- this adaptations may include radiologic aggravation and monitoring of CRF, ferritin,
LDH, d-dimers, NT-proBNP, troponin I, GOT, GPT, blood count
Other: Monitoring for aggravation
Monitor patients on CPAP or NIV and analyzing possible variables that may predict
failure, namely:
- lymphopenia
- thrombocytopenia
- CRP
- ferritin
- LDH
- troponin I
- NT-ProBNP
- Liver enzymes
- D-dimers
- radiologic aggravation " 1 day and 1 week after starting NIV or CPAP
Other: Evaluate HACOR score effectivity in this patients
Apply the HACOR score after starting NIV and CPAP and later verify if it was effective in
predicting NIV/CPAP failure
Inclusion Criteria:
- Patients with acute respiratory failure due to COVID-19 who have initiated NIV or
CPAP based on assistant clinician decision
Exclusion Criteria:
- Patients with imediate indication to invasive mechanical ventilation
- Patients with any formal contraindication to noninvasive respiratory support
Hospital General Universitario Morales Meseguer
Murcia, Spain
Investigator: Antonio Esquinas
Contact: 0034609321966
antmesquinas@gmail.com
Miguel Guia
00351915774975
miguelguia7@gmail.com
Antonio Esquinas
0034609321966
antmesquinas@gmail.com